There have been 46,794 confirmed and suspected cases in Africa this year through Nov. 3, including 1,081 deaths, the WHO said in a report issues on Monday. The most affected country is the Democratic ...

Mpox cases have risen by 500% in Africa this year, driven by the new Clade Ib strain, which is more deadly and infectious. With 48,000 suspected cases and 1,048 deaths reported in 19 countries ...

The clade Ib variant is a new form of the virus that was declared a global health emergency by the World Health Organization ...

The UK Health Security Agency has identified the first case of the mpox variant Clade Ib in Britain. The variant, linked to a global health emergency, was found in a patient traveling from Africa. It ...

In India, the first case of Mpox was reported on July 14, 2022, in Kerala, followed by cases in Delhi and other regions. Most of these cases involved individuals with a history of international ...

New Delhi: The Indian Council of Medical Research (ICMR) has invited domestic firms to manufacture quick Mpox detection tests as concerns persist after India became the third country to report the ...

British health officials say they have identified four cases of the new, more infectious version of mpox that first emerged ...

Mpox (formerly known as monkeypox) is a viral disease caused by the monkeypox virus, which belongs to the same family of viruses as smallpox. Few new cases emerged in India this year during September.

Some 1,100 people across Africa have died from mpox, the African Union's health agency said Thursday, warning that the epidemic was "going out of control" without further action. "Mpox is going ...

Mpox, formerly known as monkeypox, drew global attention in 2022 during an outbreak that affected the U.S., Europe, Australia and many other countries. The virus comes in two distinct forms or "clades ...

An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organisations said on Wednesday.

Reuters The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of ...